Roberto Ranza1, Sueli Carneiro2, Abrar A Qureshi2, Gladys Martins2, Jose Joaquim Rodrigues2, Ricardo Romiti2, Thiago Bitar M Barros2, Jamille Carneiro2, Ana Luisa Sampaio2, Rachel Grynszpan2, Juliana Markus2, Rogerio Melo Costa Pinto2, Claudia Goldenstein-Schainberg2. 1. From the Rheumatology Unit, Hospital de Clinicas, and Department of Statistics, Faculdade de Matemática, Universidade Federal Uberlândia, Minas Gerais; Dermatology Department and Rheumatology Department, Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro; Rheumatology Unit, Hospital Universitário de Brasilia, Brasilia; Department of Dermatology, Hospital de Clinicas da Universidade de São Paulo; Rheumatology Division, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil; Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.R. Ranza, MD, Professor, Rheumatology Unit; J.J. Rodrigues, MD, Dermatology Unit; J. Markus, MD, Rheumatology Unit, Hospital de Clinicas, Universidade Federal Uberlândia; S. Carneiro, MD, PhD, Associate Professor, Dermatology and Rheumatology Department;A.L. Sampaio, MD, Dermatology Department, Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro; A.A. Qureshi, MD, MPH, Professor and Chair, Department of Dermatology, Warren Alpert Medical School, Brown University; G. Martins, MD, Professor of Dermatology; J. Carneiro, MD, Rheumatology Unit, Hospital Universitário de Brasilia; R. Romiti, MD, Professor, Department of Dermatology, Hospital de Clinicas da Universidade de São Paulo; T.B. Barros, MD, Rheumatology Division, Faculdade de Medicina; C. Goldenstein-Schainberg, MD, PhD, Professor, Disciplina de Reumatologia Faculdade de Medicina, Universidade de São Paulo; R. Grynszpan, MD, Dermatology Department, Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro; R.M. Pinto, PhD, Professor, Department of Statistics, Faculdade de Matemática, Universidade Federal Uberlândia. robertoranza@gmail.com. 2. From the Rheumatology Unit, Hospital de Clinicas, and Department of Statistics, Faculdade de Matemática, Universidade Federal Uberlândia, Minas Gerais; Dermatology Department and Rheumatology Department, Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro; Rheumatology Unit, Hospital Universitário de Brasilia, Brasilia; Department of Dermatology, Hospital de Clinicas da Universidade de São Paulo; Rheumatology Division, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil; Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.R. Ranza, MD, Professor, Rheumatology Unit; J.J. Rodrigues, MD, Dermatology Unit; J. Markus, MD, Rheumatology Unit, Hospital de Clinicas, Universidade Federal Uberlândia; S. Carneiro, MD, PhD, Associate Professor, Dermatology and Rheumatology Department;A.L. Sampaio, MD, Dermatology Department, Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro; A.A. Qureshi, MD, MPH, Professor and Chair, Department of Dermatology, Warren Alpert Medical School, Brown University; G. Martins, MD, Professor of Dermatology; J. Carneiro, MD, Rheumatology Unit, Hospital Universitário de Brasilia; R. Romiti, MD, Professor, Department of Dermatology, Hospital de Clinicas da Universidade de São Paulo; T.B. Barros, MD, Rheumatology Division, Faculdade de Medicina; C. Goldenstein-Schainberg, MD, PhD, Professor, Disciplina de Reumatologia Faculdade de Medicina, Universidade de São Paulo; R. Grynszpan, MD, Dermatology Department, Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro; R.M. Pinto, PhD, Professor, Department of Statistics, Faculdade de Matemática, Universidade Federal Uberlândia.
Abstract
OBJECTIVE: To determine the prevalence of psoriatic arthritis (PsA) in a large cohort of Brazilian patients with psoriasis (PsO) being seen at dermatology centers. METHODS: A multicenter study was conducted in 4 university dermatology clinics. In each center, consecutive patients with confirmed diagnoses of PsO were evaluated by a rheumatologist. Individuals were classified as having PsA according to the ClASsification criteria for Psoriatic ARthritis (CASPAR). Laboratory tests and radiographs were performed, as needed, based on the clinical judgment of the rheumatologist. RESULTS: A total of 524 patients with PsO were evaluated. The mean age was 48.5 ± 14.5 years, 50% were women, and the mean PsO duration was 15.4 ± 11.7 years. A diagnosis of PsA was documented in 175 patients (33%), of whom 49% were newly identified by the rheumatologist. Most individuals with PsA (72%) had peripheral involvement, 11% had isolated axial involvement, and 17% had both peripheral and axial involvement. Dactylitis occurred in 20% and clinical enthesitis in 30% of the patients. Laboratory and/or radiograph tests were necessary for a definitive diagnosis of PsA in 42 of 175 individuals (24%). CONCLUSION: In our study, one-third of Brazilian patients with PsO, followed in dermatology settings, were diagnosed with PsA by a rheumatologist. Almost half of subjects with PsA had no previous diagnosis. A collaboration between dermatologists and rheumatologists is greatly needed to establish earlier PsA diagnoses and adequate multidisciplinary management.
OBJECTIVE: To determine the prevalence of psoriatic arthritis (PsA) in a large cohort of Brazilian patients with psoriasis (PsO) being seen at dermatology centers. METHODS: A multicenter study was conducted in 4 university dermatology clinics. In each center, consecutive patients with confirmed diagnoses of PsO were evaluated by a rheumatologist. Individuals were classified as having PsA according to the ClASsification criteria for Psoriatic ARthritis (CASPAR). Laboratory tests and radiographs were performed, as needed, based on the clinical judgment of the rheumatologist. RESULTS: A total of 524 patients with PsO were evaluated. The mean age was 48.5 ± 14.5 years, 50% were women, and the mean PsO duration was 15.4 ± 11.7 years. A diagnosis of PsA was documented in 175 patients (33%), of whom 49% were newly identified by the rheumatologist. Most individuals with PsA (72%) had peripheral involvement, 11% had isolated axial involvement, and 17% had both peripheral and axial involvement. Dactylitis occurred in 20% and clinical enthesitis in 30% of the patients. Laboratory and/or radiograph tests were necessary for a definitive diagnosis of PsA in 42 of 175 individuals (24%). CONCLUSION: In our study, one-third of Brazilian patients with PsO, followed in dermatology settings, were diagnosed with PsA by a rheumatologist. Almost half of subjects with PsA had no previous diagnosis. A collaboration between dermatologists and rheumatologists is greatly needed to establish earlier PsA diagnoses and adequate multidisciplinary management.
Authors: Beatriz F Leite; Melissa A Morimoto; Carina M F Gomes; Barbara N C Klemz; Patrícia S Genaro; Nittin Shivappa; James R Hébert; Nágila R T Damasceno; Marcelo M Pinheiro Journal: Adv Rheumatol Date: 2022-04-06
Authors: Ahmed Ibrahim Abd Elneam; Ghadah Alhetheli; Mohammed Saleh Al-Dhubaibi; Ali Ismaeil Ali Abd Alrheam; Ahmed El-Sayed Hassan Journal: J Clin Aesthet Dermatol Date: 2022-08
Authors: Sandro C Furiati; Jonatas S Catarino; Marcos V Silva; Rafaela F Silva; Rayane B Estevam; Reginaldo B Teodoro; Sanivia L Pereira; Meire Ataide; Virmondes Rodrigues; Denise B R Rodrigues Journal: Sci Rep Date: 2019-05-17 Impact factor: 4.379